Abstract
Protein phosphatase 2A (PP2A) inhibition causes hyperphosphorylation of tau and APP in Alzheimer's disease (AD). However, the mechanisms underlying the downregulation of PP2A activity in AD brain remain unclear. We demonstrate that Cancerous Inhibitor of PP2A (CIP2A), an endogenous PP2A inhibitor, is overexpressed in AD brain. CIP2A-mediated PP2A inhibition drives tau/APP hyperphosphorylation and increases APP β-cleavage and Aβ production. Increase in CIP2A expression also leads to tau mislocalization to dendrites and spines and synaptic degeneration. In mice, injection of AAV-CIP2A to hippocampus induced AD-like cognitive deficits and impairments in long-term potentiation (LTP) and exacerbated AD pathologies in neurons. Indicative of disease exacerbating the feedback loop, we found that increased CIP2A expression and PP2A inhibition in AD brains result from increased Aβ production. In summary, we show that CIP2A overexpression causes PP2A inhibition and AD-related cellular pathology and cognitive deficits, pointing to CIP2A as a potential target for AD therapy.
Citations
Nov 2, 2019·Aging Cell·Jinwang YeJian-Zhi Wang
Feb 20, 2020·The Journal of Biological Chemistry·Otto KaukoJukka Westermarck
Oct 21, 2018·Journal of Cancer Research and Clinical Oncology·Hirota FujikiMasami Suganuma
Jun 28, 2020·Brain and Behavior·Xia ChenLin-Xiao Wang
Jul 12, 2020·Aging·Lu WanXiaochuan Wang
Dec 14, 2018·Frontiers in Molecular Neuroscience·Qing ZhangXiaochuan Wang
Feb 26, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Hui WeiRong Liu
Aug 21, 2020·Aging Cell·Jinwang YeJian-Zhi Wang
Sep 22, 2020·Brain Communications·Joni MerisaariJukka Westermarck
Jan 2, 2020·International Journal of Molecular Sciences·Tao ZhangTae Ho Lee
Sep 1, 2019·Current Alzheimer Research·Yang-Ping ShentuRong Liu
Oct 19, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ying ZhouYangping Shentu
Nov 27, 2020·Frontiers in Aging Neuroscience·Xuewen XiaoLu Shen
Mar 17, 2020·Current Neuropharmacology·Deepak KumarLalit Sharma
Nov 4, 2020·European Journal of Medicinal Chemistry·Lisha WangBengt Winblad
Dec 23, 2020·Journal of Ethnopharmacology·Hui-Ling ZhaoYong-He Zhang
Feb 6, 2021·Journal of Neuroinflammation·Qiang LiuYu-Qing Wu
Mar 27, 2020·Saudi Journal of Biological Sciences·Richard L JayarajRami Beiram
Jan 29, 2021·The Journal of Biological Chemistry·Otto KaukoJukka Westermarck
Feb 1, 2021·Journal of Molecular Modeling·Pragya KushwahaShafiul Haque
Apr 6, 2021·ACS Chemical Neuroscience·Yiming PanJuan Kong
Apr 6, 2021·Current Research in Immunology·Mohd Moin KhanRiitta Lahesmaa
Apr 28, 2021·Molecular Neurobiology·Yangjie JiaChao Ma
Jul 13, 2021·Frontiers in Molecular Neuroscience·Xiaomin YinWei Qian
Jul 10, 2021·Biochemical Society Transactions·Iris VerbinnenVeerle Janssens
Aug 27, 2021·Neuroscience Bulletin·Wenjing ZhangLi Zhang
Apr 28, 2019·Neuroscience Letters·Nima N NaseriWenjie Luo